BEGIN:VCALENDAR
VERSION:2.0 
PRODID:-/-/EN
BEGIN:VEVENT
SUMMARY:Society Symposium 'Individualised Medicine and the role of Genomics', AGM & Presidential Address 
UID:1127
DESCRIPTION:1.30 pm\n\nRegistration and Coffee\n\n2.00 pm\nGene Therapy of Rare Diseases: Current Status and Future Prospect\nProfessor Robert Wynn, Consultant Paediatric Haematologist / Bone Marrow Transplant; Honorary Professor of Clinical Paediatric Haematology and Cell Therapies, Royal Manchester Children's Hospital\n\n2.35pm\nThe Manchester Rare Conditions Centre in the Era of Personalised Medicine\nProfessor Siddharth Banka, Consultant Geneticist, St. Mary's Hospital\n\nTalk synopsis: \n\nDiagnosing, understanding, managing, and treating Rare Conditions (RCs) remains challenging. People living with RCs often require a lifetime of complex care that can profoundly impact education, financial stability, and physical and mental health. To address these unmet needs and benefit from the extraordinary regional infrastructure and expertise across the life course, the Manchester University NHS Foundation Trust and partners established the Manchester Rare Conditions Centre (MRCC) in 2021 as a virtual platform with a mission to improve the lives of individuals and families living with RCs. Since its formation the MRCC has evolved into an effective platform to link and coordinate RCs-related work in the region, break silos, facilitate cross-institutional, cross-disciplinary, cross-theme connections, and to enable the sharing of best practices. It is positioned to improve the lives of those affected by RCs by anticipating shifts in policies, scoping new opportunities, and undertaking advanced planning to develop new large-scale, high-impact projects and programmes. The work of the MRCC is enhancing efficiency, preserving, and enhancing the legacy of partners, and developing institutional memory for specialist tasks. In this talk I will focus on the '4 Ps' of rare conditions related Personalised Medicine work happening in Manchester - Prediction and Prevention of disease; Precise diagnoses; Personalised and targeted interventions;  and a Participatory role for patients. \n\nLearning objectives:\n\nUnderstanding the unmet needs of patients with rare conditionsStructure and function of the Manchester Rare Conditions CentreRole of precision medicine in rare conditions3.10pm\nBreak\n\n3.40 pm\nPrecision Medicine in Cancer\nDr Matthew Krebs, Clinical Senior Lecturer in Experimental Cancer Medicine and Honorary Consultant in Medical Oncology, The Christie NHS FT\n\nTalk synopsis:\n\nThis talk will cover with a brief history of how precision medicine has evolved in cancer and the relevance of DNA mutations for treatment selection. Oncology has played a leading role in implementing precision medicine in routine practice, supported by the NHS Genomics Medicine Service. Innovation in genomic testing with liquid biopsy, specifically circulating tumour DNA (ctDNA), will be covered and how this is being implemented in the NHS for the benefit of our patients. Finally, the talk will cover current state-of-the-art Precision Medicine research studies and future direction.  \n\nLearning Objectives:\n\nUnderstand relevance of genomic mutations in treatment selection for cancer patientsUnderstand structure of the NHS Genomics Medicine Service for cancer patients in EnglandGain insight into future direction of travel for precision medicine in cancer with liquid biopsy and state-of-the art clinical trials4.15pm\nAdvances in cystic fibrosis management\nDr Anna Shawcross, Consultant in Paediatric Respiratory Medicine, Manchester\n\nLearning objectives:\n\nAn understanding of the state of current cystic fibrosis (CF) clinical care including diagnosis via newborn screening, medical management of CF and current prognosis into adulthoodAn introduction to CFTR modulator drugs, including mode of action and clinical effectsThe challenges of diagnosis CF and CFTR-related disorders.4.50pm\nCoffee\n\n5.20 pm \nAnnual General Meeting followed by the Presidential Address of Dr Ruth Gottstein, Consultant Neonatologist, Manchester University NHS FT\n"Individualised medicine leading to advances in neonatal care"\n\nTalk synopsis:\n\nHow we have progressed in neonatal medicine to a more individualised treatment strategy for our small and vulnerable patients. \n\n6.10 pm\nClose\n\nThis meeting has been supported by Genedrive with\nSubsistence and Exhibition space only and had no involvement with the agenda or content.\n\n
DTSTART:20241016T130000Z
DTEND:20241016T173000Z
LOCATION:MANDEC 3rd Floor, University Dental Hospital, Higher Cambridge Street, Manchester M15 6FH
END:VEVENT
END:VCALENDAR